Global Prokaryotic Expression Systems Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 294.49 Million |
 Market Size (Forecast Year) |
USD 808.17 Million |
 CAGR |
% |
| Major Markets Players |
>全球原核表达系统市场，按宿主类型（古菌、枯草芽孢杆菌、谷氨酸棒状杆菌、大肠杆菌系统、产碱假单胞菌）、产品（氨基酸、生物聚合物、抗坏血酸、色素、酶、抗生素、脂肪酶、仪器、感受态细胞、试剂、表达载体、服务）、应用（研究应用、治疗性蛋白质、工业蛋白质）、最终用户（学术研究、生物技术公司、制药、合同研究组织）划分 - 行业趋势和预测到 2029 年。
原核表达系统市场分析和规模
原核系统是实验室和工业中用于蛋白质过量生产的最广泛使用的系统。该系统主要基于大肠杆菌，尽管芽孢杆菌种的使用也越来越多。原核系统允许快速生产大量重组蛋白。这些微生物的使用得益于简单且廉价的细菌细胞培养和众所周知的转录和翻译机制。原核系统还具有易于进行基因改造和拥有大量可用的细菌突变体的优势。
Data Bridge Market Research 分析，原核表达系统市场在 2021 年为 2.9449 亿美元，预计到 2029 年将达到 8.0817 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 13.45%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
原核表达系统市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（纯硅光纤、多晶光纤、聚合物光纤）、光纤类型（单模光纤和多模光纤）、用途（可重复使用、一次性）、最终用户（医院、门诊手术中心、专科诊所、合同研究组织 (CRO)、诊断实验室）、应用（图像传输、激光信号传输、照明、激光焊接、光纤共焦扫描） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Agilent Technologies, Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), QIAGEN (Germany), Promega Corporation (U.S.), Thermo Fischer Scientific, Inc. (U.S.), Takara Bio Inc. (Japan), GenScript (U.S.), Lonza (Switzerland), New England Biolabs (U.S.), Oxford Expression Technology (U.K.), LifeSensors Inc. (U.S.), Proteogenix (France), Synthetic Genomics Inc. (U.S.), Peak Proteins Ltd (U.K.), Sino Biological Inc. (China), ARTES Biotechnology GmbH (Germany) |
|
Market Opportunities |
|
Market Definition
The prokaryotic expression system is one of the most commonly used genetic engineering approaches for the expression and secretion of exogenous target genes. The vector and the expression host are the basic elements of any expression system. The prokaryotic system is the most widely used system for protein overproduction, both in the laboratory and in industry. This system is primarily based on the bacteria E. coli, though Bacillus species are increasingly being used.
Global Prokaryotic Expression Systems Market Dynamics
Drivers
- Rising use of E. coli bacteria
The market is expanding due to the large-scale production of a protein using E. coli bacteria, as E. coli is the most commonly used artificial expression host. E. coli is widely used because of its genomic and physiological sequencing system, which is responsible for simplifying the cloning procedure and making the E. coli host the most popular in the pharmaceutical industry. Furthermore, this process is responsible for increasing the binding strength of promoter region 7 and aiding in transcription. Furthermore, prokaryotic expression is critical in the pharmaceutical and biotechnology industries. These factors are expected to boost growth.
- Research and development activities to bolster the growth
The market for prokaryotic expression systems is dominated by the research and applications. The segment's growth is attributed to the large-scale application and benefits such as prokaryotes' rapid growth and use in molecular biology, genetics, and biochemistry research. Prokaryotic organisms are essential to all living organisms and play an important role in recycling nutrients by decomposing dead organisms. As a result of this, they are widely used in research as healthy bacteria. Furthermore, studies are being conducted to improve the activity of prokaryotic in the pharmaceutical and biotechnology industries in order to improve the action of pharmaceutical drugs. However, the current trend of moving genetic parts from prokaryotic to eukaryotic for the corresponding DNA-binding sequencing by E. coli is likely to boost the market growth.
Opportunities
- Technological development to create opportunities
Increasing advancement in genomic sequences along with technological advancement for instance, in April 2020, Bio-Rad laboratories, Inc., a leading life science research organisation based in the United States, acquired Celsee, Inc. to provide instruments and consumables for the isolation, detection, and analysis of single cells.in proteomics which will further boost various opportunities for the growth of the prokaryotic expression systems market in the above mentioned forecast period.
Restraints/Challenges
- High cost of protein expression
High barrier on the entry of the new organisation along with high cost of protein expression reagents will obstruct the market's growth rate. Limited disease awareness, high product costs, poor economic conditions, and a lack of favourable insurance systems all limit the adoption of prokaryotic expression systems products in developing regions around the world.
This prokaryotic expression systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prokaryotic expression systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent developments
- In April 2020, US-based leading life science research organization, Bio-Rad laboratories, Inc., acquired Celsee, Inc. to offers instruments and consumables for the isolation, detection, and analysis of single cells.
Global Prokaryotic Expression Systems Market Scope
原核表达系统市场根据宿主类型、产品、应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
主机类型
- 古菌
- 枯草芽孢杆菌
- 谷氨酸棒状杆菌
- 大肠杆菌系统
- 产碱假单胞菌
产品
应用
- 研究应用
- 治疗性蛋白质
- 工业蛋白质
最终用户
- 学术研究
- 生物技术公司
- 药品
- 合同研究组织
原核表达系统市场区域分析/见解
对原核表达系统市场进行了分析，并按国家、宿主类型、产品、应用和最终用户提供了市场规模洞察和趋势。
原核表达系统市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于美国和加拿大等国家在基因组测序和蛋白质组学方面的不断进步以及创新等因素，北美在原核生物表达系统市场中占据主导地位。
预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长，因为推动该地区增长的因素是市场参与者进行的累积研究以及对基因表达研发活动的投资不断增加可能会推动市场增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
原核表达系统市场还为您提供每个国家/地区资本设备医疗保健支出增长、原核表达系统市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对原核表达系统市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和原核表达系统市场份额分析
原核表达系统市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对原核表达系统市场的关注有关。
原核表达系统市场的一些主要参与者包括：
- 安捷伦科技公司（美国）
- 默克集团（德国）
- Bio-Rad Laboratories, Inc.（美国）
- QIAGEN（德国）
- Promega 公司 (美国)
- Thermo Fischer Scientific, Inc.（美国）
- Takara Bio Inc.（日本）
- GenScript (美国)
- 新英格兰生物实验室（美国）
- 牛津表达技术公司（英国）
- LifeSensors Inc.（美国）
- 龙沙（瑞士）
- Proteogenix（法国）
- Synthetic Genomics Inc.（美国）
- Peak Proteins Ltd（英国）
- 中国北京义翘神州生物技术有限公司 (中国)
- ARTES Biotechnology GmbH（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
